Dare Bioscience (DARE) Interest Expenses (2013 - 2026)
Dare Bioscience's (DARE) quarterly Interest Expenses came in at $165726.0 in Q4 2025, up 521.82% YoY from $26651.6 in Q4 2024, and down 92.15% on a QoQ basis from $2.1 million in Q3 2025.
Dare Bioscience (DARE) Interest Expenses (2013 - 2026) Analysis & Trends
Dare Bioscience (DARE) has 13 years of Interest Expenses data on file, last reported at $165726.0 in Q4 2025.
- Quarterly Interest Expenses rose 521.82% year-over-year to $165726.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $571913.0 (down 7.06% YoY) and the FY2025 annual result came in at $113.7 million, down 1.55% from the prior year.
- Interest Expenses slipped to $165726.0 in Q4 2025, from $2.1 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $2.6 million in Q1 2025 to a low of -$39288.0 in Q4 2024.
- A 5-year average of $456078.4 and a median of $118000.0 in 2021 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2024 — Interest Expenses tumbled 109.82% — and 2025, when it soared 1133.16%.
- Tracing DARE's Interest Expenses over 5 years: stood at $119000.0 in 2021, then sank by 42.02% to $69000.0 in 2022, then jumped by 479.71% to $400000.0 in 2023, then plunged by 109.82% to -$39288.0 in 2024, then surged by 521.82% to $165726.0 in 2025.
- The last three Interest Expenses figures came in at $165726.0 (Q4 2025), $2.1 million (Q3 2025), and $2.1 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Dare Bioscience | 12.36 Mn | -256,055.23 | -132,343.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 923,974.00 |
| Jun 30, 2026 | 923,974.00 |
| Dec 31, 2025 | 165,726.00 |
| Dec 31, 2025 | 165,726.00 |
| Sep 30, 2025 | 2.11 Mn |
| Sep 30, 2025 | 2.11 Mn |
| Jun 30, 2025 | 2.12 Mn |
| Jun 30, 2025 | 2.12 Mn |
| Mar 31, 2025 | 2.58 Mn |
| Mar 31, 2025 | 2.58 Mn |
| Dec 31, 2024 | -39,288.00 |
| Dec 31, 2024 | -39,288.00 |
| Sep 30, 2024 | 227,573.00 |
| Sep 30, 2024 | 227,573.00 |
| Jun 30, 2024 | 217,902.00 |
| Jun 30, 2024 | 217,902.00 |
| Mar 31, 2024 | 209,138.00 |
| Mar 31, 2024 | 209,138.00 |
| Dec 31, 2023 | 400,000.00 |
| Dec 31, 2023 | 400,000.00 |